✦ LIBER ✦

A randomized evaluation of adjunctive chemoimmunotherapy versus immunotherapy in patients with resected metastatic melanoma

✍ Scribed by Charles M. Balch; Douglas R. Murray; Cary A. Presant; Al Bartolucci

Book ID: 103719451
Publisher: Elsevier Science
Year: 1981
Tongue: English
Weight: 179 KB
Volume: 7
Category: Article
ISSN: 0360-3016
DOI: 10.1016/0360-3016(81)90247-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Histopathological analysis of metastatic

Histopathological analysis of metastatic melanoma deposits in patients receiving adoptive immunotherapy with tumor-infiltrating lymphocytes

✍ D. J. Cole; J. K. Taubenberger; B. A. Pockaj; J. R. Yannelli; C. Carter; J. Carr 📂 Article 📅 1994 🏛 Springer-Verlag 🌐 English ⚖ 632 KB

Adjuvant immunotherapy with nonviable my

Adjuvant immunotherapy with nonviable mycobacterium smegmatis in resected primary lung carcinoma a randomized clinical trial of 219 patients

✍ Guy Decroix; Claude Chastang; Dominique Fichet; Bernard Asselain; Bernard Lebeau 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 603 KB

A phase 2, randomized study of SB-485232

A phase 2, randomized study of SB-485232, rhIL-18, in patients with previously untreated metastatic melanoma

✍ Ahmad A. Tarhini; Michael Millward; Paul Mainwaring; Richard Kefford; Ted Logan; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 140 KB 👁 1 views

A phase III randomized trial of dacarbaz

A phase III randomized trial of dacarbazine and carboplatin with and without tamoxifen in the treatment of patients with metastatic melanoma

✍ Sanjiv S. Agarwala; William Ferri; William Gooding; John M. Kirkwood 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 3 views

## BACKGROUND. Metastatic melanoma is a disease associated with a poor prognosis, and dacarbazine is still the reference agent. The authors conducted a randomized trial to test the benefit of adding tamoxifen to dacarbazine and carboplatin chemotherapy for previously untreated patients with metast

A randomized phase II trial of adjuvant

A randomized phase II trial of adjuvant chemotherapy with uracil/tegafur and gemcitabine versus gemcitabine alone in patients with resected pancreatic cancer

✍ Hideyuki Yoshitomi; Akira Togawa; Fumio Kimura; Hiroshi Ito; Hiroaki Shimizu; Hi 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB 👁 1 views

Chemo-immunotherapy in patients with met

Chemo-immunotherapy in patients with metastatic melanoma using sequential treatment with decarbazine and recombinant human interleukin-2: evaluation of hematologic and immunologic parameters and correlation with clinical response

✍ Rut Isacson; Eli Kedar; Vivian Barak; Zulma Gazit; Oded Yurim; Inna Kalichman; H 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 576 KB